{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:46:28Z","timestamp":1790628388392,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jns.2025.125711","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:47Z","timestamp":1766793647000},"page":"125711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"480","author":[{"given":"Warda","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om H.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Tamhankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Feroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Choudhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.125711_bb0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management General neurology","volume":"89","author":"Mollan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2025.125711_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0025-6196(12)61045-3","article-title":"Idiopathic intracranial hypertension","volume":"69","author":"Radhakrishnan","year":"1994","journal-title":"Mayo Clin. Proc."},{"issue":"8","key":"10.1016\/j.jns.2025.125711_bb0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","article-title":"The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana","volume":"45","author":"Durcan","year":"1988","journal-title":"Arch. Neurol."},{"issue":"16","key":"10.1016\/j.jns.2025.125711_bb0020","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"issue":"7764","key":"10.1016\/j.jns.2025.125711_bb0025","first-page":"138","article-title":"Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study","volume":"341","author":"Sinclair","year":"2010","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.jns.2025.125711_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207866","article-title":"Weight management interventions for adults with idiopathic intracranial hypertension: a systematic review and practice recommendations","volume":"101","author":"Abbott","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.125711_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/EB.S492845","article-title":"Acetazolamide for idiopathic intracranial hypertension: an up-to-date review in 2025","volume":"17","author":"Naqvi","year":"2025","journal-title":"Eye Brain"},{"issue":"16","key":"10.1016\/j.jns.2025.125711_bb0040","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2025.125711_bb0045","first-page":"1","article-title":"Infographic: landmark trials in neuro-ophthalmology\u2014results of the idiopathic intracranial hypertension treatment trial (IIHTT)","author":"Lowe","year":"2025","journal-title":"Eye (Basingstoke)."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/08820538.2017.1353810","article-title":"Complications of optic nerve sheath fenestration as a treatment for idiopathic intracranial hypertension","volume":"33","author":"Gilbert","year":"2018","journal-title":"Semin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/neurintsurg-2021-017361","article-title":"Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations","volume":"14","author":"Townsend","year":"2021","journal-title":"J. Neurointerv. Surg."},{"key":"10.1016\/j.jns.2025.125711_bb0060","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"E. Clin. Med."},{"key":"10.1016\/j.jns.2025.125711_bb0065","doi-asserted-by":"crossref","first-page":"q1645","DOI":"10.1136\/bmj.q1645","article-title":"GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment","volume":"386","author":"Mahase","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.125711_bb0070","series-title":"Glucagon-Like Peptide-1 Receptor Agonists","author":"Collins","year":"2024"},{"issue":"404","key":"10.1016\/j.jns.2025.125711_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.jns.2025.125711_bb0080","first-page":"478","article-title":"The expanding burden of idiopathic intracranial hypertension","volume":"33","author":"Mollan","year":"2019","journal-title":"Eye (Basingstoke)."},{"issue":"4","key":"10.1016\/j.jns.2025.125711_bb0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajo.2006.12.040","article-title":"Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)","volume":"143","author":"Daniels","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.jns.2025.125711_bb0090","article-title":"GLP-1 receptor agonists: beyond diabetes-what the neurosurgeon needs to know","volume":"5","author":"Abdulrazeq","year":"2024","journal-title":"Neurosurg. Pract."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with Semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jns.2025.125711_bb0100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management","volume":"89","author":"Mollan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2025.125711_bb0105","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/acn3.52300","article-title":"Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study","volume":"12","author":"Azzam","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2025.125711_bb0110","article-title":"Semaglutide as an adjunctive therapy to standard management for idiopathic intracranial hypertension: a real-world data-based retrospective analysis","author":"Azzam","year":"2024","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.jns.2025.125711_bb0115","first-page":"2090","article-title":"The effect of glucagon-like peptide-1 agonists on ocular parameters in idiopathic intracranial hypertension patients: a retrospective study","volume":"39","author":"Kravetz","year":"2025","journal-title":"Eye (Basingstoke)."},{"key":"10.1016\/j.jns.2025.125711_bb0120","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.jns.2025.125711_bb0125","first-page":"1159","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurol. Int."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2016.08.004","article-title":"Update on idiopathic intracranial hypertension","volume":"35","author":"Wall","year":"2017","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2025.125711_bb0135","author":"Ottawa Hospital Research Institute"},{"key":"10.1016\/j.jns.2025.125711_bb0140","series-title":"Cochrane Bias","article-title":"RoB 2: a revised Cochrane risk-of-bias tool for randomized trials","year":"2025"},{"key":"10.1016\/j.jns.2025.125711_bb0145","series-title":"Cochrane","article-title":"Chapter 7: considering bias and conflicts of interest among the included studies","year":"2025"},{"key":"10.1016\/j.jns.2025.125711_bb0150","series-title":"Centre for Evidence-Based Medicine (CEBM)","article-title":"What if the data I want are reported for the wrong time point?","year":"2025"},{"key":"10.1016\/j.jns.2025.125711_bb0155","series-title":"Study Results. A Trial to Determine the Efficacy and Safety of Presendin in IIH","year":"2025"},{"issue":"2","key":"10.1016\/j.jns.2025.125711_bb0160","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1002\/edm2.70019","article-title":"Efficacy of Tirzepatide Dual GIP\/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension A Real-World Propensity Score-Matched Study","volume":"8","author":"Azzam","year":"2025","journal-title":"Endocrinol Diabetes Metab."},{"issue":"5","key":"10.1016\/j.jns.2025.125711_bb0165","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/awad003","article-title":"The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial","volume":"146","author":"Mitchell","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-023-01631-z","article-title":"Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension","volume":"24","author":"Krajnc","year":"2023","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.jns.2025.125711_bb0175","first-page":"1","article-title":"Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study","author":"O\u2019Leary","year":"2025","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jns.2025.125711_bb0180","doi-asserted-by":"crossref","unstructured":"G.S. Sioutas, W. Mualem, J. Reavey-Cantwell, D.J. Rivet, GLP-1 receptor agonists in idiopathic intracranial hypertension, JAMA Neurol. 82(9) (2025 Jul 14) 887-894[cited 2025 Aug 12]; Available from https:\/\/pubmed.ncbi.nlm.nih.gov\/40658395\/.","DOI":"10.1001\/jamaneurol.2025.2020"},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-018-0919-2","article-title":"European headache federation guideline on idiopathic intracranial hypertension","volume":"19","author":"Hoffmann","year":"2018","journal-title":"J. Headache Pain"},{"issue":"9","key":"10.1016\/j.jns.2025.125711_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70358","article-title":"Efficacy and safety of GLP-1 and dual GIP\/GLP-1 receptor agonists in idiopathic intracranial hypertension: a systematic review and meta-analysis","volume":"32","author":"Stefanou","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2025.125711_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2018.07.032","article-title":"The relationship between optic disc volume, area, and fris\u00e9n score in patients with idiopathic intracranial hypertension","volume":"195","author":"Sheils","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.jns.2025.125711_bb0200","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1007\/s00415-024-12481-3","article-title":"Exploring the utility of retinal optical coherence tomography as a biomarker for idiopathic intracranial hypertension: a systematic review","volume":"271","author":"Prem Senthil","year":"2024","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.125711_bb0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.21608\/bjas.2021.198002","article-title":"Correlation between automated perimetry and optical coherence tomography in post treatment follow-up of papilledema due to idiopathic intracranial hypertension","volume":"6","author":"Beheiry","year":"2021","journal-title":"Benha J. Appl. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNO.0000000000000181","article-title":"Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension","volume":"35","author":"Rizzo","year":"2015","journal-title":"J. Neuroophthalmol."},{"issue":"4","key":"10.1016\/j.jns.2025.125711_bb0215","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4103\/ijo.IJO_2103_21","article-title":"Optical coherence tomography features and correlation of functional and structural parameters in patients of idiopathic intracranial hypertension","volume":"70","author":"Banerjee","year":"2022","journal-title":"Indian J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41467-020-14309-w","article-title":"Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics","volume":"11","author":"Ast","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12987-025-00652-x","article-title":"Glucagon-like peptide-1 receptor modulates cerebrospinal fluid secretion and intracranial pressure in rats","volume":"22","author":"Jensen","year":"2025","journal-title":"Fluids Barriers CNS."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-97081-5","article-title":"Comparison of bariatric surgery and community weight management for idiopathic intracranial hypertension in a multicenter retrospective cohort study","volume":"15","author":"Mirdad","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jns.2025.125711_bb0235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","article-title":"Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial","volume":"78","author":"Mollan","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.125711_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-025-01420-y","article-title":"Current understanding of the pathophysiology of idiopathic intracranial hypertension","volume":"25","author":"Lowe","year":"2025","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.jns.2025.125711_bb0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/life11050393","article-title":"Neurosurgical CSF diversion in idiopathic intracranial hypertension: a narrative review","volume":"11","author":"Sunderland","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jns.2025.125711_bb0250","series-title":"Optic Nerve Decompression. Atlas of Endoscopic Sinus and Skull Base Surgery","first-page":"157","author":"Barham","year":"2025"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:19:16Z","timestamp":1767935956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25023330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0022510X25023330"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.125711","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.125711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125711"}}